A detailed history of Shell Asset Management CO transactions in Penumbra Inc stock. As of the latest transaction made, Shell Asset Management CO holds 1,011 shares of PEN stock, worth $243,003. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,011
Previous 1,068 5.34%
Holding current value
$243,003
Previous $192,000 2.08%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.64 - $210.12 $9,327 - $11,976
-57 Reduced 5.34%
1,011 $196,000
Q1 2024

Jul 31, 2024

SELL
$220.09 - $273.15 $14,746 - $18,301
-67 Reduced 5.9%
1,068 $192,000
Q1 2024

May 14, 2024

SELL
$220.09 - $273.15 $8,803 - $10,926
-40 Reduced 3.4%
1,135 $253,000
Q4 2023

Feb 14, 2024

SELL
$181.44 - $260.22 $302,279 - $433,526
-1,666 Reduced 58.64%
1,175 $296,000
Q3 2023

Nov 08, 2023

SELL
$240.69 - $338.77 $11,793 - $16,599
-49 Reduced 1.7%
2,841 $687,000
Q2 2023

Jul 28, 2023

SELL
$271.54 - $344.06 $380,427 - $482,028
-1,401 Reduced 32.65%
2,890 $994,000
Q1 2023

May 15, 2023

SELL
$220.43 - $278.69 $3,306 - $4,180
-15 Reduced 0.35%
4,291 $1.2 Million
Q4 2022

Feb 07, 2023

SELL
$151.88 - $228.5 $138,666 - $208,620
-913 Reduced 17.49%
4,306 $958,000
Q3 2022

Nov 14, 2022

SELL
$120.36 - $205.88 $164,291 - $281,026
-1,365 Reduced 20.73%
5,219 $990,000
Q2 2022

Aug 09, 2022

BUY
$116.09 - $227.33 $1,276 - $2,500
11 Added 0.17%
6,584 $820,000
Q1 2022

May 04, 2022

SELL
$187.51 - $283.98 $254,263 - $385,076
-1,356 Reduced 17.1%
6,573 $1.46 Million
Q4 2021

Feb 09, 2022

SELL
$238.08 - $288.0 $1.16 Million - $1.4 Million
-4,873 Reduced 38.06%
7,929 $2.28 Million
Q3 2021

Nov 04, 2021

BUY
$250.72 - $291.24 $2.63 Million - $3.05 Million
10,473 Added 449.68%
12,802 $3.41 Million
Q2 2021

Aug 12, 2021

BUY
$235.0 - $310.7 $547,315 - $723,620
2,329 New
2,329 $638,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.